Role of cannabis in cardiovascular disorders

Journal of Thoracic Disease

Volumn 9, Issue 7, 2017, Pages 2079-2092

  Goyal, Hemant ^a   Awad, Hamza H ^a   Ghali, Jalal K ^a  

^a MERCER UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Cannabis; Cardiovascular; Marijuana; Myocardial infarction (MI); Stroke; Synthetic marijuana

Indexed keywords

CANNABINOID; CANNABIS; DRONABINOL; ENDOCANNABINOID;

ACUTE CORONARY SYNDROME; BRAIN BLOOD VESSEL; BRAIN ISCHEMIA; CANNABIS USE; CARDIOVASCULAR DISEASE; CAUSAL ATTRIBUTION; DISEASE ASSOCIATION; HEART INFARCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MOLECULAR DYNAMICS; MYOPERICARDITIS; NONHUMAN; ORTHOSTATIC HYPOTENSION; PERICARDITIS; PERIOPERATIVE PERIOD; PERIPHERAL CIRCULATION; PHYSICAL ACTIVITY; PREOPERATIVE PERIOD; REVIEW; RISK ASSESSMENT; SMOKING; SUDDEN DEATH; SYSTOLIC BLOOD PRESSURE; TAKOTSUBO CARDIOMYOPATHY;

EID: 85026454522     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.21037/jtd.2017.06.104     Document Type: Review

References (105)

1. Crime UNOoDa. World Drug Report 2016. Available online: http://www.unodc.org/wdr2016/
2. Green KM, Johnson RM, Milam AJ, et al. Racial differences and the role of neighborhood in the sequencing of marijuana and tobacco initiation among urban youth. Subst Abus 2016;37:507-10
3. National Conference of State Legislatures. www.ncsl. org/research/health/state-medical-marijuana-laws.aspx. Accessed October 10, 2016
4. Hughes A, Lipari RN, Williams M. State Estimates of Adolescent Marijuana Use and Perceptions of Risk of Harm From Marijuana Use: 2013 and 2014. The CBHSQ Report Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013-2015 Dec 17 2015
5. Hoch E, Bonnetn U, Thomasius R, et al. Risks associated with the non-medicinal use of cannabis. Dtsch Arztebl Int 2015;112:271-8
6. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009;374:1383-91
7. Milroy CM, Parai JL. The histopathology of drugs of abuse. Histopathology 2011;59:579-93
8. Jouanjus E, Lapeyre-Mestre M, Micallef J, et al. Cannabis use: signal of increasing risk of serious cardiovascular disorders. J Am Heart Assoc 2014;3:e000638
9. Gaoni Y, Mechoulam R. Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish. J Am Chem Soc 1964;86:1646-47
10. Howlett AC, Barth F, Bonner TI, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002;54:161-202
11. Maccarrone M, Bab I, Bíró T, et al. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci 2015;36:277-96
12. Montecucco F, Di Marzo V. At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction. Trends Pharmacol Sci 2012;33:331-40
13. Hiley CR, Ford WR. Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling. Biol Rev Camb Philos Soc 2004;79:187-205
14. Steffens S, Pacher P. Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies. Br J Pharmacol 2012;167:313-23
15. Franz CA, Frishman WH. Marijuana Use and Cardiovascular Disease. Cardiol Rev 2016;24:158-62
16. Korantzopoulos P, Liu T, Papaioannides D, et al. Atrial fibrillation and marijuana smoking. Int J Clin Pract 2008;62:308-13
17. Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol 2002;42:64S-70S
18. Jones RT. Cardiovascular system effects of marijuana. J Clin Pharmacol 2002;42:58S-63S
19. Khiabani HZ, Mørland J, Bramness JG. Frequency and irregularity of heart rate in drivers suspected of driving under the influence of cannabis. Eur J Intern Med 2008;19:608-12
20. Korantzopoulos P. Marijuana smoking is associated with atrial fibrillation. Am J Cardiol 2014;113:1085-6
21. Sánchez Lázaro IJ, Almenar Bonet L, Sancho-Tello MJ, et al. Ventricular tachycardia due to marijuana use in a heart transplant patient. Rev Esp Cardiol 2009;62:459-61
22. Casier I, Vanduynhoven P, Haine S, et al. Is recent cannabis use associated with acute coronary syndromes? An illustrative case series. Acta Cardiol 2014;69:131-6
23. Baranchuk A, Johri AM, Simpson CS, et al. Ventricular fibrillation triggered by marijuana use in a patient with ischemic cardiomyopathy: a case report. Cases J 2008;1:373
24. Daccarett M, Freih M, Machado C. Acute cannabis intoxication mimicking brugada-like ST segment abnormalities. Int J Cardiol 2007;119:235-6
25. Pratap B, Korniyenko A. Toxic effects of marijuana on the cardiovascular system. Cardiovasc Toxicol 2012;12:143-8
26. Alonso JV, Teo BH, Pozo FJ, et al. Brugada electrocardiogram pattern induced by cannabis; is cannabis safe? Am J Emerg Med 2016;34:1738.e1-4
27. Ballard ME, de Wit H. Combined effects of acute, verylow-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers. Pharmacol Biochem Behav 2011;97:627-31
28. Dumont GJ, Kramers C, Sweep FC, et al. Cannabis coadministration potentiates the effects of "ecstasy" on heart rate and temperature in humans. Clin Pharmacol Ther 2009;86:160-6
29. Hodcroft CJ, Rossiter MC, Buch AN. Cannabis-associated myocardial infarction in a young man with normal coronary arteries. J Emerg Med 2014;47:277-81
30. Deharo P, Massoure PL, Fourcade L. Exerciseinduced acute coronary syndrome in a 24-year-old man with massive cannabis consumption. Acta Cardiol 2013;68:425-8
31. Ghannem M, Belhadj I, Tritar A, et al. [Cannabis and acute coronary syndrome with ST segment elevation]. Ann Cardiol Angeiol (Paris) 2013;62:424-8
32. Yurtdas M, Aydin MK. Acute myocardial infarction in a young man; fatal blow of the marijuana: a case report. Korean Circ J 2012;42:641-5
33. Canga Y, Osmonov D, Karatas MB, et al. Cannabis: a rare trigger of premature myocardial infarction. Anadolu Kardiyol Derg 2011;11:272-4
34. Panayiotides IM. What is the Association of Cannabis Consumption and Cardiovascular Complications? Subst Abuse 2015;9:1-3
35. Leblanc A, Tirel-Badets A, Paleiron N, et al. [Cannabis and myocardial infarction without angiographic stenosis in young patient: guilty or not guilty? A case report]. Ann Cardiol Angeiol (Paris) 2011;60:154-8
36. Mittleman MA, Lewis RA, Maclure M, et al. Triggering myocardial infarction by marijuana. Circulation 2001;103:2805-9
37. Mukamal KJ, Maclure M, Muller JE, et al. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J 2008;155:465-70
38. Frost L, Mostofsky E, Rosenbloom JI, et al. Marijuana use and long-term mortality among survivors of acute myocardial infarction. Am Heart J 2013;165:170-5
39. Arora S, Goyal H, Aggarwal P, et al. ST-segment elevation myocardial infarction in a 37-year-old man with normal coronaries-it is not always cocaine! Am J Emerg Med 2012;30:2091.e3-5
40. McLeod AL, McKenna CJ, Northridge DB. Myocardial infarction following the combined recreational use of Viagra and cannabis. Clin Cardiol 2002;25:133-4
41. Aronow WS, Cassidy J. Effect of marihuana and placebomarihuana smoking on angina pectoris. N Engl J Med 1974;291:65-7
42. Deusch E, Kress HG, Kraft B, et al. The procoagulatory effects of delta-9-tetrahydrocannabinol in human platelets. Anesth Analg 2004;99:1127-30, table of contents
43. Karch SB. Cannabis and cardiotoxicity. Forensic Sci Med Pathol 2006;2:13-8
44. O'Sullivan SE, Tarling EJ, Bennett AJ, et al. Novel timedependent vascular actions of Delta9-tetrahydrocannabinol mediated by peroxisome proliferator-activated receptor gamma. Biochem Biophys Res Commun 2005;337:824-31
45. O'Sullivan SE, Kendall DA, Randall MD. Further characterization of the time-dependent vascular effects of delta9-tetrahydrocannabinol. J Pharmacol Exp Ther 2006;317:428-38
46. O'Sullivan SE, Sun Y, Bennett AJ, et al. Time-dependent vascular actions of cannabidiol in the rat aorta. Eur J Pharmacol 2009;612:61-8
47. Vandrey R, Umbricht A, Strain EC. Increased blood pressure after abrupt cessation of daily cannabis use. J Addict Med 2011;5:16-20
48. Bonnet U. Abrupt Quitting of Long-term Heavy Recreational Cannabis Use is Not Followed by Significant Changes in Blood Pressure and Heart Rate. Pharmacopsychiatry 2016;49:23-5
49. Alshaarawy O, Elbaz HA. Cannabis use and blood pressure levels: United States National Health and Nutrition Examination Survey, 2005-2012. J Hypertens 2016;34:1507-12
50. Malinowska B, Baranowska-Kuczko M, Schlicker E. Triphasic blood pressure responses to cannabinoids: do we understand the mechanism? Br J Pharmacol 2012;165:2073-88
51. Grotenhermen F. Cannabis-associated arteritis. Vasa 2010;39:43-53
52. Karila L, Roux P, Rolland B, et al. Acute and longterm effects of cannabis use: a review. Curr Pharm Des 2014;20:4112-8
53. Cottencin O, Karila L, Lambert M, et al. Cannabis arteritis: review of the literature. J Addict Med 2010;4:191-6
54. Peyrot I, Garsaud AM, Saint-Cyr I, et al. Cannabis arteritis: a new case report and a review of literature. J Eur Acad Dermatol Venereol 2007;21:388-91
55. Lou JY, Randhawa MS, Hornacek D, et al. Images in vascular medicine. Spontaneous renal artery dissection in a cannabis user. Vasc Med 2015;20:379-80
56. Corvi F, Querques G, Lattanzio R, et al. Central retinal vein occlusion in a young patient following cannabis smoke inhalation. Eur J Ophthalmol 2014;24:437-40
57. Bucci F, Redler A, Fiengo L. Critical limb ischemia in a young man: saddle embolism or unusual presentation of thromboangiitis obliterans? Case Rep Vasc Med 2013;2013:830540
58. Ulenaers M, Buchel OC, Van Olmen A, et al. An uncommon cause of visceral arterial embolism in patients presenting with acute abdominal pain: a report of 2 cases. Acta Gastroenterol Belg 2010;73:55-60
59. Thanvi BR, Treadwell SD. Cannabis and stroke: is there a link? Postgrad Med J 2009;85:80-3
60. Rumalla K, Reddy AY, Mittal MK. Recreational marijuana use and acute ischemic stroke: A population-based analysis of hospitalized patients in the United States. J Neurol Sci 2016;364:191-6
61. Wolff V, Lauer V, Rouyer O, et al. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients. Stroke 2011;42:1778-80
62. Tsivgoulis G, Lachanis S, Papathanasiou MA, et al. Cannabis-associated angiopathy: an uncommon cause of crescendo transient ischemic attacks. Circulation 2014;130:2069-70
63. Hackam DG. Cannabis and stroke: systematic appraisal of case reports. Stroke 2015;46:852-6
64. Desbois AC, Cacoub P. Cannabis-associated arterial disease. Ann Vasc Surg 2013;27:996-1005
65. Ntlholang O, McDonagh R, Nicholson S, et al. Is intimal hyperplasia associated with cranial arterial stenosis in cannabis-associated cerebral infarction? Int J Stroke 2015;10:E56-9
66. Wolff V, Schlagowski AI, Rouyer O, et al. Tetrahydrocannabinol induces brain mitochondrial respiratory chain dysfunction and increases oxidative stress: a potential mechanism involved in cannabis-related stroke. Biomed Res Int 2015;2015:323706
67. Ince B, Benbir G, Yuksel O, et al. Both hemorrhagic and ischemic stroke following high doses of cannabis consumption. Presse Med 2015;44:106-7
68. Rumalla K, Reddy AY, Mittal MK. Association of Recreational Marijuana Use with Aneurysmal Subarachnoid Hemorrhage. J Stroke Cerebrovasc Dis 2016;25:452-60
69. Behrouz R, Birnbaum L, Grandhi R, et al. Cannabis Use and Outcomes in Patients With Aneurysmal Subarachnoid Hemorrhage. Stroke 2016;47:1371-3
70. Di Napoli M, Zha AM, Godoy DA, et al. Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage. Cerebrovasc Dis 2016;41:248-55
71. Wolff V, Armspach JP, Lauer V, et al. Cannabis-related stroke: myth or reality? Stroke 2013;44:558-63
72. Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 2007;130:3091-101
73. Wolff V, Armspach JP, Lauer V, et al. Ischaemic strokes with reversible vasoconstriction and without thunderclap headache: a variant of the reversible cerebral vasoconstriction syndrome? Cerebrovasc Dis 2015;39:31-8
74. Wolff V, Ducros A. Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache. Headache 2016;56:674-87
75. Ting JY. Reversible cardiomyopathy associated with acute inhaled marijuana use in a young adult. Clin Toxicol (Phila) 2007;45:432-4
76. Kaushik M, Alla VM, Madan R, et al. Recurrent stress cardiomyopathy with variable regional involvement: insights into etiopathogenetic mechanisms. Circulation 2011;124:e556-7
77. Rodríguez-Castro CE, Alkhateeb H, Elfar A, et al. Recurrent myopericarditis as a complication of Marijuana use. Am J Case Rep 2014;15:60-2
78. Orsini J, Blaak C, Tam E, et al. The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity. Case Rep Crit Care 2015;2015:542490
79. Shah M, Garg J, Patel B, et al. Can your heart handle the spice: A case of acute myocardial infarction and left ventricular apical thrombus. Int J Cardiol 2016;215:129-31
80. Castaneto MS, Gorelick DA, Desrosiers NA, et al. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend 2014;144:12-41
81. Bush DM, Woodwell DA. Update: Drug-Related Emergency Department Visits Involving Synthetic Cannabinoids. The CBHSQ Report Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013-2014 Oct 16 2013-2014
82. Cooper ZD. Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal. Curr Psychiatry Rep 2016;18:52
83. Tait RJ, Caldicott D, Mountain D, et al. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clin Toxicol (Phila) 2016;54:1-13
84. Obafemi AI, Kleinschmidt K, Goto C, et al. Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies. J Med Toxicol 2015;11:426-9
85. Tournebize J, Gibaja V, Kahn JP. Acute effects of synthetic cannabinoids: Update 2015. Subst Abus 2016:1-23
86. Wells DL, Ott CA. The "new" marijuana. Ann Pharmacother 2011;45:414-7
87. Taylor DR, Poulton R, Moffitt TE, et al. The respiratory effects of cannabis dependence in young adults. Addiction 2000;95:1669-77
88. Fligiel SE, Roth MD, Kleerup EC, et al. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest 1997;112:319-26
89. Roth MD, Arora A, Barsky SH, et al. Airway inflammation in young marijuana and tobacco smokers. Am J Respir Crit Care Med 1998;157:928-37
90. Tashkin DP. Effects of marijuana smoking on the lung. Ann Am Thorac Soc 2013;10:239-47
91. Wong GT, Irwin MG. Poisoning with illicit substances: toxicology for the anaesthetist. Anaesthesia 2013;68 Suppl 1:117-24
92. Karam K, Abbasi S, Khan FA. Anaesthetic consideration in a cannabis addict. J Coll Physicians Surg Pak 2015;25 Suppl 1:S2-3
93. Flisberg P, Paech MJ, Shah T, et al. Induction dose of propofol in patients using cannabis. Eur J Anaesthesiol 2009;26:192-5
94. Chesher GB, Jackson DM, Starmer GA. Interaction of cannabis and general anaesthetic agents in mice. Br J Pharmacol 1974;50:593-9
95. Frizza J, Chesher GB, Jackson DM, et al. The effect of delta 9-tetrahydrocannabinol, cannabidiol, and cannabinol on the anaesthesia induced by various anaesthetic agents in mice. Psychopharmacology (Berl) 1977;55:103-7
96. Mallat A, Roberson J, Brock-Utne JG. Preoperative marijuana inhalation-an airway concern. Can J Anaesth 1996;43:691-3
97. Kim CA, Liu R, Hsia DW. Diffuse alveolar hemorrhage induced by sevoflurane. Ann Am Thorac Soc 2014;11:853-5
98. Murray AW, Smith JD, Ibinson JW. Diffuse alveolar hemorrhage, anesthesia, and cannabis. Ann Am Thorac Soc 2014;11:1338-9
99. Bryson EO, Frost EA. The perioperative implications of tobacco, marijuana, and other inhaled toxins. Int Anesthesiol Clin 2011;49:103-18
100. Hernandez M, Birnbach DJ, Van Zundert AA. Anesthetic management of the illicit-substance-using patient. Curr Opin Anaesthesiol 2005;18:315-24
101. Jefferson DA, Harding HE, Cawich SO, et al. Postoperative analgesia in the Jamaican cannabis user. J Psychoactive Drugs 2013;45:227-32
102. Morgan CJ, Das RK, Joye A, et al. Cannabidiol reduces cigarette consumption in tobacco smokers: preliminary findings. Addict Behav 2013;38:2433-6
103. Penner EA, Buettner H, Mittleman MA. The impact of marijuana use on glucose, insulin, and insulin resistance among US adults. Am J Med 2013;126:583-9
104. Le Foll B, Trigo JM, Sharkey KA, et al. Cannabis and 9-tetrahydrocannabinol (THC) for weight loss? Med Hypotheses 2013;80:564-7
105. Waldman M, Hochhauser E, Fishbein M, et al. An ultra-low dose of tetrahydrocannabinol provides cardioprotection. Biochem Pharmacol 2013;85:1626-33